GSPs decrease cell viability and induce cell death of HNSCC cells. by Ram Prasad (305524)

The C allele at rs28416813-rev in <i>IL28B</i> promoter decreases luciferase expression. by Sreedhar Chinnaswamy (468287)

“…<p>A) Luciferase activity with p1.4IL28B constructs shows that the C allele at rs28416813-rev when present along with the T allele at rs71356849-rev decreases reporter gene expression. …”

Androgen and staurosporine synergize to decrease the relative ATP concentration in HPr-1AR cells. by Congcong Chen (796149)

“…In comparison to vehicle control, STS and to a lesser extent DHT significantly decrease the relative ATP concentration of HPr-1AR cells at 24 hours. …”

Comparison of SF-36 scores of participants with residual limb pain with a VAS score ≥5 and participants with a VAS score <5. by Martin C. Berli (9427264)

L1 animals lacking <i>adr-2</i> have decreased expression of genes regulated by insulin signaling. by Ananya Mahapatra (17041557)

Δ3C virus-induced lymphomas have decreased expression of E2F target genes. by James C. Romero-Masters (4112614)

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

Silencing AXL in human colon cancer cells does not decrease proliferation. by Diana J. Uribe (2201695)

PGRN-deficient CD4+CD25+ Treg decreased the suppressive capacity to Teff proliferation. by Fanhua Wei (659805)

PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

“…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…NR3C1, glucocorticoid receptor; NR3C2, mineralocorticoid receptor; GMEB1, glucocorticoid modulatory element binding protein 1; GRLF1, glucocorticoid receptor DNA binding factor 1; CRH, corticotropin-releasing hormone; CRHR1, corticotropin-releasing hormone receptor 1; CRHR2, corticotropin-releasing hormone receptor 2; CRHBP, corticotropin-releasing hormone binding protein; UCN, urocortin; UCN3, stresscopin (urocortin 3); FKBP5, FK506 binding protein 5.…”

OPN-deficiency decreases inflammation, oxidative stress and fibrosis in adipose tissue. by Andoni Lancha (335824)

GFP activity is decreased in DES. by Céline Portal (3876436)

“…<p><b>(a)</b> Scatterplots show that CGC number determined on histological sections (AB—PAS coloration), and GFP⁺ (Muc5b) and Muc5ac⁺ CGC number determined by immunofluorescence staining (anti-GFP and anti-Muc5ac antibody) decreased (n = 10 mice, 1 section per mouse, one symbol/mouse) after 10 days of BAK application (filled-in symbols) in one eye (PBS in the other, white-filled symbols) followed by 4 days without any treatment. …”

PKCδ inhibition decreases CXCL4-induced cord dissociation. by Joshua Jamison (470566)

Knockdown of Dp71 expression decreases the proliferation of PC12 cells. by Marcela Villarreal-Silva (208792)

Knockdown of CoREST1 decreased tumor cell-mediated macrophage migration and activation. by Sohini Mazumdar (707540)

Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

The mRNA expression levels of Mfsd2a in brain microvessels from 2- and 24-month-old mice. by Takuro Iwao (14636741)

Subjects:

Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

“…<p>GSH efflux in ARPE-19 cells incubated with two MRP1 inhibitors (75 µM MK571 and 5 mM sulfinpyrazone [SP]) for 5 h (A). …”

MFSD2A expression levels in brain microvessels from 2-, 8-, 12-, and 24-month-old mice. by Takuro Iwao (14636741)

Subjects: